Note : Pharmaceutical stocks are drawing attention in connection with the COVID-19 (Coronavirus disease 2019) vaccine. Pfizer is one of them. There is no COVID-19 vaccine yet that everyone recognize the efficacy, and it is not known how long it will take. In other words, the prices of pharmaceutical stocks related to the COVID-19 vaccine could not be assured. Pfizer stock prices fell after hitting the resistance line of 42.84. If they strongly break out that price line again, it would be a sign of rise. In that case, the next resistance(target) could be 56.12 and 68.45. If the pharmaceutical market is very strong, we may see 99 or so. It would be better to find opportunities to buy when its stock price breaks out 42.84.